Raptor Pharmaceutica (RPTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,377 | -11,542 | -10,356 | -8,106 | -6,256 |
| Depreciation Amortization | 848 | 1,015 | 1,186 | 16 | 15 |
| Accounts payable and accrued liabilities | -5,694 | 1,781 | 1,385 | 560 | 120 |
| Other Working Capital | -5,156 | 1,099 | 1,719 | 876 | -90 |
| Other Operating Activity | 8,532 | 6,736 | -2,225 | 223 | 117 |
| Operating Cash Flow | $-26,847 | $-911 | $-8,291 | $-6,431 | $-6,094 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -134 | -702 | -54 | -3 | N/A |
| Net Acquisitions | -1,629 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -20,050 | N/A |
| Sale Of Investment | 45,300 | N/A | N/A | 100 | N/A |
| Investing Cash Flow | $43,537 | $-702 | $-54 | $-19,953 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 5,000 | N/A | N/A | N/A |
| Debt Repayment | -2,106 | -2,301 | -2,484 | N/A | N/A |
| Common Stock Issued | 340 | 30 | 9 | 27,325 | N/A |
| Other Financing Activity | 6,322 | 0 | 29,185 | 4,868 | 0 |
| Financing Cash Flow | $9,556 | $2,729 | $26,710 | $32,193 | $N/A |
| Exchange Rate Effect | 380 | 12 | -30 | N/A | N/A |
| Beginning Cash Position | 28,757 | 27,629 | 9,293 | 3,021 | 9,115 |
| End Cash Position | 55,383 | 28,757 | 27,629 | 8,830 | 3,021 |
| Net Cash Flow | $26,626 | $1,128 | $18,335 | $5,809 | $-6,094 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,847 | -911 | -8,291 | -6,431 | -6,094 |
| Capital Expenditure | -134 | -702 | -54 | -3 | N/A |
| Free Cash Flow | -26,981 | -1,613 | -8,344 | -6,434 | -6,094 |